Literature DB >> 6141486

In vivo characterization of four types of opioid binding sites in rat brain.

W Sadée, M L Richards, J Grevel, J S Rosenbaum.   

Abstract

Opioid receptor multiplicity was studied in the brain of intact rats by two experimental approaches. The first involved in vivo labeling by administration of [3H] tracers s.c. to intact rats. The second method was based on ex vivo labeling by incubating fresh brain homogenates immediately after sacrifice with suitable receptor type-specific tracers. The ex vivo labeling approach thus can measure the in vivo receptor occupancy of unlabeled ligands, provided that these ligands do not equilibrate between bound and free form over the assay period. The results suggest the presence of four separate types of opioid binding sites that resemble the mu, delta, kappa, and the newly identified lambda sites.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141486     DOI: 10.1016/0024-3205(83)90474-5

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  7 in total

1.  Kappa antagonist properties of buprenorphine in non-tolerant and morphine-tolerant rats.

Authors:  S S Negus; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Buprenorphine: a unique drug with complex pharmacology.

Authors:  Kabirullah Lutfy; Alan Cowan
Journal:  Curr Neuropharmacol       Date:  2004-10       Impact factor: 7.363

3.  The antiarrhythmic and cardiac electrophysiological effects of buprenorphine.

Authors:  G Boachie-Ansah; R Sitsapesan; K A Kane; J R Parratt
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

Review 4.  Recent advances in the treatment of opiate addiction.

Authors:  Paul J Fudala; George W Woody
Journal:  Curr Psychiatry Rep       Date:  2004-10       Impact factor: 5.285

5.  Buprenorphine is an Antagonist at the ϰ Opioid Receptor.

Authors:  M L Richards; W Sadée
Journal:  Pharm Res       Date:  1985-07       Impact factor: 4.200

6.  Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies.

Authors:  Anika Mann; Sophia Liebetrau; Marie Klima; Pooja Dasgupta; Dominique Massotte; Stefan Schulz
Journal:  Sci Rep       Date:  2020-05-22       Impact factor: 4.379

Review 7.  Novel Pharmacological Approaches to the Treatment of Depression.

Authors:  Elias Elias; Ariel Y Zhang; Melissa T Manners
Journal:  Life (Basel)       Date:  2022-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.